Industry Research Reports

Home > Reports > Chemical & Material > Global Ecamsule Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Ecamsule Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 118 Pages

Report ld: 5277601

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Ecamsule market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.

Asia-Pacific is expected to experience the highest growth in the market during the forecast period.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Ecamsule market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Hubei Norna Technology
Nanjing CHICO Pharmaceutical
Hubei artec biotechnology
Hangzhou Hairui

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity(Less than 98%)
Purity(98%-99%)
Purity(More than 99%)

Segment by Application

Cosmetics
Pharmaceuticals
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Ecamsule study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Ecamsule: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Ecamsule Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Purity(Less than 98%)

1.2.3 Purity(98%-99%)

1.2.4 Purity(More than 99%)

1.3 Market Segmentation by Application

1.3.1 Global Ecamsule Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Cosmetics

1.3.3 Pharmaceuticals

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Ecamsule Revenue Estimates and Forecasts 2020-2031

2.2 Global Ecamsule Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Ecamsule Sales Estimates and Forecasts 2020-2031

2.4 Global Ecamsule Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Ecamsule Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Ecamsule Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Ecamsule Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Purity(Less than 98%) Market Size by Manufacturers

4.5.2 Purity(98%-99%) Market Size by Manufacturers

4.5.3 Purity(More than 99%) Market Size by Manufacturers

4.6 Global Ecamsule Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Ecamsule Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Ecamsule Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Ecamsule Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Ecamsule Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Ecamsule Sales and Revenue by Type (2020-2031)

7.4 North America Ecamsule Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Ecamsule Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Ecamsule Sales and Revenue by Type (2020-2031)

8.4 Europe Ecamsule Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Ecamsule Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Ecamsule Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Ecamsule Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Ecamsule Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Ecamsule Sales and Revenue by Type (2020-2031)

10.4 Central and South America Ecamsule Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Ecamsule Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Ecamsule Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Ecamsule Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Ecamsule Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Hubei Norna Technology

12.1.1 Hubei Norna Technology Corporation Information

12.1.2 Hubei Norna Technology Business Overview

12.1.3 Hubei Norna Technology Ecamsule Product Models, Descriptions and Specifications

12.1.4 Hubei Norna Technology Ecamsule Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Hubei Norna Technology Ecamsule Sales by Product in 2024

12.1.6 Hubei Norna Technology Ecamsule Sales by Application in 2024

12.1.7 Hubei Norna Technology Ecamsule Sales by Geographic Area in 2024

12.1.8 Hubei Norna Technology Ecamsule SWOT Analysis

12.1.9 Hubei Norna Technology Recent Developments

12.2 Nanjing CHICO Pharmaceutical

12.2.1 Nanjing CHICO Pharmaceutical Corporation Information

12.2.2 Nanjing CHICO Pharmaceutical Business Overview

12.2.3 Nanjing CHICO Pharmaceutical Ecamsule Product Models, Descriptions and Specifications

12.2.4 Nanjing CHICO Pharmaceutical Ecamsule Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Nanjing CHICO Pharmaceutical Ecamsule Sales by Product in 2024

12.2.6 Nanjing CHICO Pharmaceutical Ecamsule Sales by Application in 2024

12.2.7 Nanjing CHICO Pharmaceutical Ecamsule Sales by Geographic Area in 2024

12.2.8 Nanjing CHICO Pharmaceutical Ecamsule SWOT Analysis

12.2.9 Nanjing CHICO Pharmaceutical Recent Developments

12.3 Hubei artec biotechnology

12.3.1 Hubei artec biotechnology Corporation Information

12.3.2 Hubei artec biotechnology Business Overview

12.3.3 Hubei artec biotechnology Ecamsule Product Models, Descriptions and Specifications

12.3.4 Hubei artec biotechnology Ecamsule Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Hubei artec biotechnology Ecamsule Sales by Product in 2024

12.3.6 Hubei artec biotechnology Ecamsule Sales by Application in 2024

12.3.7 Hubei artec biotechnology Ecamsule Sales by Geographic Area in 2024

12.3.8 Hubei artec biotechnology Ecamsule SWOT Analysis

12.3.9 Hubei artec biotechnology Recent Developments

12.4 Hangzhou Hairui

12.4.1 Hangzhou Hairui Corporation Information

12.4.2 Hangzhou Hairui Business Overview

12.4.3 Hangzhou Hairui Ecamsule Product Models, Descriptions and Specifications

12.4.4 Hangzhou Hairui Ecamsule Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Hangzhou Hairui Ecamsule Sales by Product in 2024

12.4.6 Hangzhou Hairui Ecamsule Sales by Application in 2024

12.4.7 Hangzhou Hairui Ecamsule Sales by Geographic Area in 2024

12.4.8 Hangzhou Hairui Ecamsule SWOT Analysis

12.4.9 Hangzhou Hairui Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Ecamsule Industry Chain

13.2 Ecamsule Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Ecamsule Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Ecamsule Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Ecamsule Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Ecamsule Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Ecamsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Ecamsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Ecamsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Ecamsule Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Ecamsule Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Ecamsule Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 7. Global Ecamsule Sales by Region (2020-2025) & (MT)

Table 8. Global Ecamsule Sales by Region (2026-2031) & (MT)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Ecamsule Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 11. Global Ecamsule Production by Region (2020-2025) & (MT)

Table 12. Global Ecamsule Production by Region (2026-2031) & (MT)

Table 13. Global Ecamsule Sales by Manufacturers (2020-2025) & (MT)

Table 14. Global Ecamsule Sales Share by Manufacturers (2020-2025)

Table 15. Global Ecamsule Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Ecamsule Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Ecamsule by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ecamsule as of 2024)

Table 19. Global Ecamsule Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Ecamsule Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)

Table 21. Key Manufacturers Ecamsule Manufacturing Base and Headquarters

Table 22. Global Ecamsule Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Ecamsule Sales by Type (2020-2025) & (MT)

Table 26. Global Ecamsule Sales by Type (2026-2031) & (MT)

Table 27. Global Ecamsule Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Ecamsule Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Ecamsule ASP by Type (2020-2031) & (USD/MT)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Ecamsule Sales by Application (2020-2025) & (MT)

Table 32. Global Ecamsule Sales by Application (2026-2031) & (MT)

Table 33. Ecamsule High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Ecamsule Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Ecamsule Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Ecamsule ASP by Application (2020-2031) & (USD/MT)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Ecamsule Growth Accelerators and Market Barriers

Table 40. North America Ecamsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Ecamsule Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Ecamsule Growth Accelerators and Market Barriers

Table 43. Europe Ecamsule Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Ecamsule Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Ecamsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Ecamsule Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Ecamsule Growth Accelerators and Market Barriers

Table 48. Southeast Asia Ecamsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Ecamsule Investment Opportunities and Key Challenges

Table 50. Central and South America Ecamsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Ecamsule Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Ecamsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Hubei Norna Technology Corporation Information

Table 54. Hubei Norna Technology Description and Major Businesses

Table 55. Hubei Norna Technology Product Models, Descriptions and Specifications

Table 56. Hubei Norna Technology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 57. Hubei Norna Technology Sales Value Proportion by Product in 2024

Table 58. Hubei Norna Technology Sales Value Proportion by Application in 2024

Table 59. Hubei Norna Technology Sales Value Proportion by Geographic Area in 2024

Table 60. Hubei Norna Technology Ecamsule SWOT Analysis

Table 61. Hubei Norna Technology Recent Developments

Table 62. Nanjing CHICO Pharmaceutical Corporation Information

Table 63. Nanjing CHICO Pharmaceutical Description and Major Businesses

Table 64. Nanjing CHICO Pharmaceutical Product Models, Descriptions and Specifications

Table 65. Nanjing CHICO Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 66. Nanjing CHICO Pharmaceutical Sales Value Proportion by Product in 2024

Table 67. Nanjing CHICO Pharmaceutical Sales Value Proportion by Application in 2024

Table 68. Nanjing CHICO Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 69. Nanjing CHICO Pharmaceutical Ecamsule SWOT Analysis

Table 70. Nanjing CHICO Pharmaceutical Recent Developments

Table 71. Hubei artec biotechnology Corporation Information

Table 72. Hubei artec biotechnology Description and Major Businesses

Table 73. Hubei artec biotechnology Product Models, Descriptions and Specifications

Table 74. Hubei artec biotechnology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 75. Hubei artec biotechnology Sales Value Proportion by Product in 2024

Table 76. Hubei artec biotechnology Sales Value Proportion by Application in 2024

Table 77. Hubei artec biotechnology Sales Value Proportion by Geographic Area in 2024

Table 78. Hubei artec biotechnology Ecamsule SWOT Analysis

Table 79. Hubei artec biotechnology Recent Developments

Table 80. Hangzhou Hairui Corporation Information

Table 81. Hangzhou Hairui Description and Major Businesses

Table 82. Hangzhou Hairui Product Models, Descriptions and Specifications

Table 83. Hangzhou Hairui Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 84. Hangzhou Hairui Sales Value Proportion by Product in 2024

Table 85. Hangzhou Hairui Sales Value Proportion by Application in 2024

Table 86. Hangzhou Hairui Sales Value Proportion by Geographic Area in 2024

Table 87. Hangzhou Hairui Ecamsule SWOT Analysis

Table 88. Hangzhou Hairui Recent Developments

Table 89. Key Raw Materials Distribution

Table 90. Raw Materials Key Suppliers

Table 91. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 92. Milestones in Production Technology Evolution

Table 93. Distributors List

Table 94. Market Trends and Market Evolution

Table 95. Market Drivers and Opportunities

Table 96. Market Challenges, Risks, and Restraints

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Ecamsule Product Picture

Figure 2. Global Ecamsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Purity(Less than 98%) Product Picture

Figure 4. Purity(98%-99%) Product Picture

Figure 5. Purity(More than 99%) Product Picture

Figure 6. Global Ecamsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Cosmetics

Figure 8. Pharmaceuticals

Figure 9. Others

Figure 10. Ecamsule Report Years Considered

Figure 11. Global Ecamsule Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 13. Global Ecamsule Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Ecamsule Revenue Market Share by Region (2020-2031)

Figure 15. Global Ecamsule Sales (2020-2031) & (MT)

Figure 16. Global Ecamsule Sales (CAGR) by Region (2020-2031) (MT)

Figure 17. Global Ecamsule Sales Market Share by Region (2020-2031)

Figure 18. Global Ecamsule Capacity, Production and Utilization (2020-2031) & (MT)

Figure 19. Global Ecamsule Production Trend by Region (2020-2031) (MT)

Figure 20. Global Ecamsule Production Market Share by Region (2020-2031)

Figure 21. Production Capacity Enablers & Constraints

Figure 22. Ecamsule Production Growth Rate in North America (2020-2031) & (MT)

Figure 23. Ecamsule Production Growth Rate in Europe (2020-2031) & (MT)

Figure 24. Ecamsule Production Growth Rate in China (2020-2031) & (MT)

Figure 25. Ecamsule Production Growth Rate in Japan (2020-2031) & (MT)

Figure 26. Top 5 and Top 10 Manufacturers Ecamsule Sales Volume Market Share in 2024

Figure 27. Global Ecamsule Revenue Market Share Ranking (2024)

Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 29. Purity(Less than 98%) Revenue Market Share by Manufacturer in 2024

Figure 30. Purity(98%-99%) Revenue Market Share by Manufacturer in 2024

Figure 31. Purity(More than 99%) Revenue Market Share by Manufacturer in 2024

Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 34. Global Ecamsule Sales Market Share by Type (2020-2031)

Figure 35. Global Ecamsule Revenue Market Share by Type (2020-2031)

Figure 36. Global Ecamsule Sales Market Share by Application (2020-2031)

Figure 37. Global Ecamsule Revenue Market Share by Application (2020-2031)

Figure 38. North America Ecamsule Sales YoY (2020-2031) & (MT)

Figure 39. North America Ecamsule Revenue YoY (2020-2031) & (US$ Million)

Figure 40. North America Top 5 Manufacturers Ecamsule Sales Revenue (US$ Million) in 2024

Figure 41. North America Ecamsule Sales Volume (MT) by Type (2020- 2031)

Figure 42. North America Ecamsule Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 43. North America Ecamsule Sales Volume (MT) by Application (2020-2031)

Figure 44. North America Ecamsule Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. US Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 47. Mexico Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 48. Europe Ecamsule Sales YoY (2020-2031) & (MT)

Figure 49. Europe Ecamsule Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Europe Top 5 Manufacturers Ecamsule Sales Revenue (US$ Million) in 2024

Figure 51. Europe Ecamsule Sales Volume (MT) by Type (2020-2031)

Figure 52. Europe Ecamsule Sales Revenue (US$ Million) by Type (2020-2031)

Figure 53. Europe Ecamsule Sales Volume (MT) by Application (2020-2031)

Figure 54. Europe Ecamsule Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Germany Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 56. France Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 57. U.K. Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 58. Italy Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 59. Russia Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Ecamsule Sales YoY (2020-2031) & (MT)

Figure 61. Asia-Pacific Ecamsule Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Asia-Pacific Top 8 Manufacturers Ecamsule Sales Revenue (US$ Million) in 2024

Figure 63. Asia-Pacific Ecamsule Sales Volume (MT) by Type (2020- 2031)

Figure 64. Asia-Pacific Ecamsule Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 65. Asia-Pacific Ecamsule Sales Volume (MT) by Application (2020-2031)

Figure 66. Asia-Pacific Ecamsule Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Indonesia Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 68. Japan Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 71. India Ecamsule Revenue (2020-2031) & (US$ Million)

Figure 72. Central and South America Ecamsule Sales YoY (2020-2031) & (MT)

Figure 73. Central and South America Ecamsule Revenue YoY (2020-2031) & (US$ Million)

Figure 74. Central and South America Top 5 Manufacturers Ecamsule Sales Revenue (US$ Million) in 2024

Figure 75. Central and South America Ecamsule Sales Volume (MT) by Type (2021-2031)

Figure 76. Central and South America Ecamsule Sales Revenue (US$ Million) by Type (2020-2031)

Figure 77. Central and South America Ecamsule Sales Volume (MT) by Application (2020-2031)

Figure 78. Central and South America Ecamsule Sales Revenue (US$ Million) by Application (2020-2031)

Figure 79. Brazil Ecamsule Revenue (2020-2025) & (US$ Million)

Figure 80. Argentina Ecamsule Revenue (2020-2025) & (US$ Million)

Figure 81. Middle East, and Africa Ecamsule Sales YoY (2020-2031) & (MT)

Figure 82. Middle East and Africa Ecamsule Revenue YoY (2020-2031) & (US$ Million)

Figure 83. Middle East and Africa Top 5 Manufacturers Ecamsule Sales Revenue (US$ Million) in 2024

Figure 84. Middle East and Africa Ecamsule Sales Volume (MT) by Type (2021-2031)

Figure 85. South America Ecamsule Sales Revenue (US$ Million) by Type (2020-2031)

Figure 86. Middle East and Africa Ecamsule Sales Volume (MT) by Application (2020-2031)

Figure 87. Middle East and Africa Ecamsule Sales Revenue (US$ Million) by Application (2020-2031)

Figure 88. GCC Countries Ecamsule Revenue (2020-2025) & (US$ Million)

Figure 89. Turkey Ecamsule Revenue (2020-2025) & (US$ Million)

Figure 90. Egypt Ecamsule Revenue (2020-2025) & (US$ Million)

Figure 91. South Africa Ecamsule Revenue (2020-2025) & (US$ Million)

Figure 92. Ecamsule Industry Chain Mapping

Figure 93. Regional Ecamsule Manufacturing Base Distribution (%)

Figure 94. Ecamsule Production Process

Figure 95. Regional Ecamsule Production Cost Structure

Figure 96. Channels of Distribution (Direct Vs Distribution)

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Ecamsule market? zhanKai

The top companies in the global Ecamsule market are Hubei Norna Technology、Nanjing CHICO Pharmaceutical、Hubei artec biotechnology.

Related Reports

Ecamsule- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ecamsule was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 119
USD 3950.00
(Single User License)
Global Ecamsule Market Research Report 2026
The global Ecamsule market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 121
USD 2900.00
(Single User License)
Global Ecamsule Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ecamsule market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 73
USD 4250.00
(Single User License)
Ecamsule- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ecamsule was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 88
USD 3950.00
(Single User License)
Global Ecamsule Market Research Report 2025
The global market for Ecamsule was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 85
USD 2900.00
(Single User License)
Global Ecamsule Market Insights, Forecast to 2030
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Published Date: 2024-04-15
Pages: 72
USD 4900.00
(Single User License)
Ecamsule - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Published Date: 2024-01-16
Pages: 82
USD 3950.00
(Single User License)
Global Ecamsule Market Research Report 2024
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Published Date: 2024-01-04
Pages: 76
USD 2900.00
(Single User License)

Ecamsule- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ecamsule was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 119
USD 3950.00 (Single User License)
Global Ecamsule Market Research Report 2026
The global Ecamsule market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 121
USD 2900.00 (Single User License)
Global Ecamsule Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ecamsule market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 73
USD 4250.00 (Single User License)
Ecamsule- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ecamsule was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 88
USD 3950.00 (Single User License)
Global Ecamsule Market Research Report 2025
The global market for Ecamsule was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 85
USD 2900.00 (Single User License)
Global Ecamsule Market Insights, Forecast to 2030
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Published: 2024-04-15
Pages: 72
USD 4900.00 (Single User License)
Ecamsule - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Published: 2024-01-16
Pages: 82
USD 3950.00 (Single User License)
Global Ecamsule Market Research Report 2024
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Published: 2024-01-04
Pages: 76
USD 2900.00 (Single User License)